+380.0%
CRWD vs MRNA
+34.8%
+345.2%
-44.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | +5.4% | -6.4% | -1.1% |
| 7D | -3.0% | -1.1% | -1.9% | -3.0% |
| 30D | -6.8% | +126.1% | -132.9% | -8.5% |
| 3M | +19.6% | +190.0% | -170.4% | +14.1% |
| 6M | +87.1% | +157.2% | -70.1% | +80.1% |
| YTD | +76.4% | +388.2% | -311.8% | +58.1% |
| 1Y | +90.8% | +467.0% | -376.2% | +67.2% |
| 3Y | +380.0% | +36.1% | +343.9% | +348.1% |
| All | +380.0% | +34.8% | +345.2% | +348.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling